Drugs / cT84.66
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00645710 | Feb 2005 → Feb 2018 | metastasis from malignant tumor of colon, rectal cancer | City of Hope Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cT84.66 | “Patients also receive yttrium Y 90 anti-CEA monoclonal antibody cT84.66 IV over 25 minutes on day 9.” NCT00645710 ↗ |
| Action | Deplete | “may kill any tumor cells that remain after surgery” NCT00645710 ↗ |
| Route | Intravenous | “cT84.66 IV over 25 minutes” NCT00645710 ↗ |